In this network meta-analysis investigating sGC stimulators for HF management, only vericiguat 10 mg was effective in reducing the incidence of the composite cardiovascular mortality and HF hospitalization, with an acceptable safety profile. Here, SGCB is linked to hydrops fetalis.